홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /화합물

Camptothecin

HCID 24360
새 노트새 반응견적 요청하기
인쇄 미리보기

데이터를 보충하는 중입니다. 잠시 후 페이지를 새로 고치면 최신 내용을 볼 수 있습니다

기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
7689-03-4
표준 SMILES
CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1
InChIKey
VSJKWCGYPAHWDS-FQEVSTJZSA-N
분자식
C20H16N2O4
평균 분자량
348.4 g/mol
단동위원소 질량
348.11100699

개요

Camptothecin is a pyranoindolizinoquinoline that is pyrano[3',4':6,7]indolizino[1,2-b]quinoline which is substituted by oxo groups at positions 3 and 14, and by an ethyl group and a hydroxy group at position 4 (the S enantiomer). It has a role as an antineoplastic agent, an EC 5.99.1.2 (DNA topoisomerase) inhibitor, a genotoxin and a plant metabolite. It is a delta-lactone, a quinoline alkaloid, a tertiary alcohol and a pyranoindolizinoquinoline.

이름 및 식별자

우선 이름
Camptothecin
IUPAC
(19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione
영어명
(+)-Camptothecin
분자식
C20H16N2O4
분자량
348.35

이름 및 동의어

camptothecinCamptothecine7689-03-4(S)-(+)-Camptothecin(+)-Camptothecind-Camptothecin20(S)-Camptothecine(+)-Camptothecine21,22-Secocamptothecin-21-oic acid lactoneNSC94600NSC-94600DTXSID0030956
이름 더 보기
CaMpathecin(20S)-CAMPTOTHECIN5,6-DIHYDROXY-7-GLUCURONOSYLFLAVONECAMPTOTHECIN, CAMPTOTHECA ACUMINATA1,6-DIHYDROXY-7-GLUCURONOSYLFLAVONECS-1388
(4S)-4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dioneXT3Z54Z28A(19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dioneCHEBI:276561H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (S)-(4S)-4-ETHYL-4-HYDROXY-1H-PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLINE-3,14(4H,12H)-DIONE(19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo(11.8.0.02,11.04,9.015,20)henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (S)-

데이터베이스 식별자

물성

구조 계산 물성보충 중

XLogP
1
극성 표면적
79.7 Ų
수소 결합 공여자 수
1
수소 결합 수용자 수
5
회전 가능 결합 수
1
무거운 원자 수
26
형식 전하
0
복잡도
742

실험 및 물리화학적 성질

Drugs · 2건

Pharmaceuticals -> Listed in ZINC15

Pharmaceuticals -> Antibiotics

Melting Point275-277 °C
Collision Cross Section · 2건

178.35 Ų [M+K]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

181.9 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

물리화학적 성질

녹는점
260 °C · 260 °C (dec.)(lit.)
끓는 점
482.73 °C · 482.73°C (rough estimate)
밀도
1.3112 · 1.3112 (rough estimate)
굴절률
1.57 · 1.5700 (estimate)
저장 조건
2 · 2-8°C
용해도
4 · 클로로포름/메탄올(4:1): 4mg/mL
물리적 상태
고체
산도 계수 (pKa)
10.83 · pKa 10.83 (Uncertain)
색상
노란색
수용성
불용성
Merck
14 · 14,1735

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 6건

Danger

H301 (98%): Toxic if swallowed [Danger Acute toxicity, oral]

P203, P264, P270, P280, P301+P316, P318, P321, P330, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 50 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Danger

H301 (97.1%): Toxic if swallowed [Danger Acute toxicity, oral]

유해성 정보

Regulatory InformationStatus: Active Update: 10-11-2008 https://echa.europa.eu/registration-dossier/-/registered-dossier/4979
Hazard Classes and Categories · 2건

Acute Tox. 3 (98%)

Acute Tox. 3 (97.1%)

안전 데이터

wgk
3
rtecs
UQ0492000
ridadr
UN 1544 6.1/PG 3
HS 번호
29399990
risk_code
36/37/38-25-20/21/22
hazard_code
T,Xi,Xn
safety_code
45-36/37/39-26-36
포장분류
Ⅲ
위험 등급
6.1
위험 참고 사항
Irritant
Hazard Classifications
Acute Tox. 3 OralMuta. 1B
스토리지 클래스
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects

화학 및 산업

약리 정보

Pharmacodynamics · 1건

Camptothecin demonstrated strong anticancer activity in preliminary clinical trials but also low solubility and adverse drug reaction. Camptothecin is believed to be a potent topoisomerase inhibitor that interferes with the essential function of topoisomerase in DNA replication.

Mechanism of ActionCamptothecin binds to the topoisomerase I and DNA complex resulting in a ternary complex, stabilizing it and preventing DNA re-ligation and therefore causes DNA damage which results in apoptosis.
MeSH Pharmacological Classification · 2건

Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity.

Compounds that inhibit the activity of DNA TOPOISOMERASE I.

응용 분야 · 3건

개요Camptothecin is an alkaloid derived from Xi Shu (Camptotheca acuminata), which belongs to Nyssaceae. The traditional Chinese medicine Camptotheca acuminata (Xi Shu) has been collected in the Compilation of Chinese Herbal Medicine, Chinese Materia Medica, and Great Dictionary of Chinese Medicine. Camptotheca acuminata (Xi Shu) is widely distributed in the basin of Yangtze river and the southwestern provinces. The main medicinal parts of Camptotheca acuminata (Xi Shu) are root bark and fruit, which get rid of heat and toxic materials and eliminate the disease.

역사In 1966, Wall M E et al. from the United States isolated an alkaloid from Camptotheca acuminata and defined its chemical structure. The invitro anticancer tests revealed the anticancer activity of the tryptophan-terpene alkaloid, which is known as camptothecin and received widely concern. In 1975, Corey etal. first opened the door for the chiral synthesis of camptothecin, but the reaction step was long and the yield rate was very low. It was not until 1997 that Ciufolini etal. developed a new method for the synthesis of camptothecin by five steps, with a total yield rate up to 51%. The great breakthrough in the chemical synthesis of camptothecin has made its extensive application become a reality.Hydroxycamptothecin, as a camptothecin derivative with a hydroxyl group on the tenth carbon atom, is widely used for the treatment of various cancers. In 1969, researchers from Shanghai Institute of Materia Medica found that hydroxycamptothecin possessed potent anticancer activity and low toxicity. And this finding promoted the production and clinical application of hydroxycamptothecin, but its usage was interrupted for technology and quality. In the 1980s, hydroxycamptothecin was reproduced for clinical application with an improvement in producing technology, and hydroxycamptothecin got its approval number in 1986 for clinical usage in China. In the 1990s, the US Food and Drug Administration approved the clinical application of topotecan and irinotecan, which played a significant role in the prevention and treatment of cancers.

관련 반응

62건
반응 기록 만들기
HRID 255805 반응식
HRID 255805반응물로uspto-grants-1987_10
HRID 255806 반응식
HRID 255806반응물로uspto-grants-1987_10
HRID 255807 반응식
HRID 255807반응물로uspto-grants-1987_10
HRID 255808 반응식
HRID 255808반응물로uspto-grants-1987_10
HRID 255809 반응식
HRID 255809반응물로uspto-grants-1987_10
HRID 255810 반응식
HRID 255810반응물로uspto-grants-1987_10
HRID 255811 반응식
HRID 255811반응물로uspto-grants-1987_10
HRID 260182 반응식
HRID 260182생성물로uspto-grants-1996_06
1 / 8 페이지

화합물 노트

불러오는 중…

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
더보기
새 노트새 반응견적 요청하기
CAS
7689-03-4
PubChem CID
24360
DTXSID
DTXSID0030956
ChEMBL
CHEMBL65
ChEBI
CHEBI:27656
UNII
XT3Z54Z28A
EC Number
444-280-6、616-407-7
Nikkaji
J2.266G
BRN
631069 · 631069
안정성
1 · 제공된 대로 구매일로부터 1년 동안 안정적입니다. DMSO 용액은 -20°C에서 최대 3개월 동안 보관할 수 있습니다.
InChI
1S/C20H16N2O4/c1-2-20(25)14-8-16-17-12(7-11-5-3-4-6-15(11)21-17)9-22(16)18(23)13(14)10-26-19(20)24/h3-8,25H,2,9-10H2,1H3/t20-/m0/s1
InChIKey
VSJKWCGYPAHWDS-FQEVSTJZSA-N
SMILES
CC[C@@]1(O)C(=O)OCC2=C1C=C3N(Cc4cc5ccccc5nc34)C2=O
LogP
1.74 · 1.740

화학적 성질

light yellow crystal powde

용도Antitumor alkaloid. Binds irreversible to the DNA-topoisomerase I complex, inhibiting the reassociation of DNA after cleavage by topoisomerase I and traps the enzyme in a covalent linkage with DNA. A cytotoxic antitumor agent

상·하류 제품 정보

상류 원료

Methanol solution

하류 제품

이리노테칸Camtobell염산염나트륨캠프토테신(S)-11-DiMethoxyMethyl-4-ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-디아자-디벤조[b,h]플루오렌-3,13-디온토포테카나세테이트

추가 설명

정의ChEBI: A pyranoindolizinoquinoline that is pyrano[3',4':6,7]indolizino[1,2-b]quinoline which is substituted by oxo groups at positions 3 and 14, and by an ethyl group and a hydroxy group at position 4 (the S enantiomer).